Complete filter‐based cerebral embolic protection with transcatheter aortic valve replacement

Complete filter‐based cerebral embolic protection with transcatheter aortic valve replacement INTRODUCTIONTranscatheter aortic valve replacement (TAVR) is recommended in patients with symptomatic severe aortic valve stenosis (AS) and an elevated surgical risk , and is serving a growing proportion of patients . As with surgical aortic valve replacement TAVR comes with a 30‐day major stroke rate of approximately 2–5% . TAVR requires large bore catheter navigation through the arterial vasculature and the implantation of a bioprosthesis within a degenerated aortic valve, which may provoke intraprocedural tissue dislodgment. Indeed, transcranial Doppler, brain magnetic resonance imaging (MRI) and histopathology studies suggest cerebral embolization in the vast majority of TAVR procedures . Silent brain lesions and (micro‐) infarcts may not be trivial, as they are associated with neurocognitive deterioration .Dedicated deflecting and filter‐based devices were designed to reduce cerebral embolization. The DEFLECT‐III trial demonstrated fewer ischemic brain lesions and preserved neurocognition with the TriGuard deflector . The Sentinel transcatheter cerebral embolic protection (TCEP) device (Claret medical, Santa Rosa, CA) provides filters to the brachiocephalic trunk and the left common carotid artery and thus omits the left vertebral artery. Recent studies demonstrated debris capture in almost all patients undergoing TAVR with Sentinel TCEP . Three randomized trials compared brain‐MRIs several days after TAVR in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Catheterization and Cardiovascular Interventions Wiley
Loading next page...
 
/lp/wiley/complete-filter-based-cerebral-embolic-protection-with-transcatheter-gPWow7Frr0
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
1522-1946
eISSN
1522-726X
D.O.I.
10.1002/ccd.27323
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONTranscatheter aortic valve replacement (TAVR) is recommended in patients with symptomatic severe aortic valve stenosis (AS) and an elevated surgical risk , and is serving a growing proportion of patients . As with surgical aortic valve replacement TAVR comes with a 30‐day major stroke rate of approximately 2–5% . TAVR requires large bore catheter navigation through the arterial vasculature and the implantation of a bioprosthesis within a degenerated aortic valve, which may provoke intraprocedural tissue dislodgment. Indeed, transcranial Doppler, brain magnetic resonance imaging (MRI) and histopathology studies suggest cerebral embolization in the vast majority of TAVR procedures . Silent brain lesions and (micro‐) infarcts may not be trivial, as they are associated with neurocognitive deterioration .Dedicated deflecting and filter‐based devices were designed to reduce cerebral embolization. The DEFLECT‐III trial demonstrated fewer ischemic brain lesions and preserved neurocognition with the TriGuard deflector . The Sentinel transcatheter cerebral embolic protection (TCEP) device (Claret medical, Santa Rosa, CA) provides filters to the brachiocephalic trunk and the left common carotid artery and thus omits the left vertebral artery. Recent studies demonstrated debris capture in almost all patients undergoing TAVR with Sentinel TCEP . Three randomized trials compared brain‐MRIs several days after TAVR in

Journal

Catheterization and Cardiovascular InterventionsWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off